247 related articles for article (PubMed ID: 31324858)
21. New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis.
Sakamoto S; Shimizu H; Isshiki T; Nakamura Y; Usui Y; Kurosaki A; Isobe K; Takai Y; Homma S
Sci Rep; 2022 Jan; 12(1):1134. PubMed ID: 35064161
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial DNA in bronchoalveolar lavage fluid is associated with the prognosis of idiopathic pulmonary fibrosis: a single cohort study.
Fukihara J; Sakamoto K; Ikeyama Y; Furukawa T; Teramachi R; Kataoka K; Kondoh Y; Hashimoto N; Ishii M
Respir Res; 2024 May; 25(1):202. PubMed ID: 38730452
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Qiu M; Chen Y; Ye Q
Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341
[TBL] [Abstract][Full Text] [Related]
24. The Role of Serum 1,25-Dihydroxy Vitamin D3 and PCT in Idiopathic Pulmonary Fibrosis.
Yang L; Zhai Z; Zhang J
Int J Gen Med; 2022; 15():8081-8092. PubMed ID: 36389018
[TBL] [Abstract][Full Text] [Related]
25. Plasma microRNAs are associated with acute exacerbation in idiopathic pulmonary fibrosis.
Min H; Fan S; Song S; Zhuang Y; Li H; Wu Y; Cai H; Yi L; Dai J; Gao Q
Diagn Pathol; 2016 Nov; 11(1):135. PubMed ID: 27881157
[TBL] [Abstract][Full Text] [Related]
26. Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.
Tsushima K; Yamaguchi K; Kono Y; Yokoyama T; Kubo K; Matsumura T; Ichimura Y; Abe M; Terada J; Tatsumi K
Pulm Pharmacol Ther; 2014 Dec; 29(2):233-40. PubMed ID: 24836398
[TBL] [Abstract][Full Text] [Related]
27. Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis.
Teramachi R; Kondoh Y; Kataoka K; Taniguchi H; Matsuda T; Kimura T; Yokoyama T; Yamano Y; Furukawa T; Sakamoto K; Hashimoto N; Hasegawa Y
Respir Med; 2018 Oct; 143():147-152. PubMed ID: 30261987
[TBL] [Abstract][Full Text] [Related]
28. Predictors of acute exacerbation in biopsy-proven idiopathic pulmonary fibrosis.
Kishaba T; Hozumi H; Fujisawa T; Nei Y; Enomoto N; Sugiura H; Kitani M; Suda T
Respir Investig; 2020 May; 58(3):177-184. PubMed ID: 32205147
[TBL] [Abstract][Full Text] [Related]
29. Progranulin and Activin A Concentrations are Elevated in Serum from Patients with Acute Exacerbations of Idiopathic Pulmonary Fibrosis.
Xie T; Han L; Chen Y; Wu H
Lung; 2021 Oct; 199(5):467-473. PubMed ID: 34462814
[TBL] [Abstract][Full Text] [Related]
30. Association of serum concentrations of irisin and the adipokines adiponectin and leptin with epicardial fat in cardiovascular surgery patients.
Kaneda H; Nakajima T; Haruyama A; Shibasaki I; Hasegawa T; Sawaguchi T; Kuwata T; Obi S; Arikawa T; Sakuma M; Amano H; Toyoda S; Fukuda H; Inoue T
PLoS One; 2018; 13(8):e0201499. PubMed ID: 30071056
[TBL] [Abstract][Full Text] [Related]
31. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.
Moon SW; Park MS; Kim YS; Jang J; Lee JH; Lee CT; Chung JH; Shim HS; Lee KW; Kim SS; Lee SH; Yoon HI
BMC Pulm Med; 2019 Oct; 19(1):177. PubMed ID: 31615505
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporin A in the treatment of acute exacerbation of idiopathic pulmonary fibrosis.
Sakamoto S; Homma S; Miyamoto A; Kurosaki A; Fujii T; Yoshimura K
Intern Med; 2010; 49(2):109-15. PubMed ID: 20075573
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
[TBL] [Abstract][Full Text] [Related]
34. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.
Ashizawa N; Yahata T; Quan J; Adachi S; Yoshihara K; Tanaka K
Gynecol Oncol; 2010 Oct; 119(1):65-9. PubMed ID: 20674961
[TBL] [Abstract][Full Text] [Related]
35. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).
Iwata T; Yoshino I; Yoshida S; Ikeda N; Tsuboi M; Asato Y; Katakami N; Sakamoto K; Yamashita Y; Okami J; Mitsudomi T; Yamashita M; Yokouchi H; Okubo K; Okada M; Takenoyama M; Chida M; Tomii K; Matsuura M; Azuma A; Iwasawa T; Kuwano K; Sakai S; Hiroshima K; Fukuoka J; Yoshimura K; Tada H; Nakagawa K; Nakanishi Y;
Respir Res; 2016 Jul; 17(1):90. PubMed ID: 27450274
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.
Arai T; Kagawa T; Sasaki Y; Sugawara R; Sugimoto C; Tachibana K; Kitaichi M; Akira M; Hayashi S; Inoue Y
Respirology; 2016 Nov; 21(8):1431-1437. PubMed ID: 27460223
[TBL] [Abstract][Full Text] [Related]
37. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis--Extended analysis of pirfenidone trial in Japan.
Kondoh Y; Taniguchi H; Ebina M; Azuma A; Ogura T; Taguchi Y; Suga M; Takahashi H; Nakata K; Sugiyama Y; Kudoh S; Nukiwa T
Respir Investig; 2015 Nov; 53(6):271-8. PubMed ID: 26521104
[TBL] [Abstract][Full Text] [Related]
39. Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer.
Kobayashi H; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi T
Respirology; 2017 Oct; 22(7):1379-1385. PubMed ID: 28543987
[TBL] [Abstract][Full Text] [Related]
40. Correlation between serum bilirubin levels and the severity as well as the prognosis of idiopathic pulmonary fibrosis.
Shi S; Liu Y; Qiu X; Cao M; Xiao Y; Yan X
Chron Respir Dis; 2020; 17():1479973120957676. PubMed ID: 32909821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
